Poland· PL-100219853
Tisseel
A all other therapeutic products product containing preparat złożony, registered in Poland by Baxter Polska Sp. z o.o.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Preparat złożony is registered in 2 of 19 countries.
Countries holding a registration under ATC V03A (all other therapeutic products), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Preparat złożony · ATC V03A
2 / 19 countries
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Preparat złożony
- Manufacturer
- Baxter Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- V03A
- ATC class
- ALL OTHER THERAPEUTIC PRODUCTS
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 9
- gtin05909990747887
- gtin05909990747894
- gtin05909990747900
- gtin05909990959358
- gtin05909990959365
- gtin05909990959372
- gtin05909991315870
- gtin05909991315887
- gtin05909991315894
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V03A
All other therapeutic products, as other registers publish it.
- PolandBocheńska lecznicza sól jodowo-bromowaZakład Przeróbki Solanek Jodowo-Bromowych "SALCO" M.Ścigalski, M.Piotrowska, E.Stopa Spółka Jawna
- NorwayMetylcellulose SASykehusapotekene HF
- NorwayMetylcellulose SASykehusapotekene HF
- NorwayMetylcellulose SASykehusapotekene HF
- NorwaySteritalc F2Novatech
- NorwaySteritalc F4Novatech
- PolandTisseel LyoBaxter Polska Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9846494a-be4b-4530-8ff0-01bfac342bbd GET /v1/drugs/9846494a-be4b-4530-8ff0-01bfac342bbd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwory do sporządzania kleju do tkanek",
"source": "urpl",
"strength": "-",
"packaging": "05909990747887 ¦ Lz ¦ 54823\n1 strzykawka AST 2 ml (1 ml + 1 ml)\n05909990747894 ¦ Lz ¦ 54824\n1 strzykawka AST 4 ml (2 ml + 2 ml)\n05909990747900 ¦ Lz ¦ 54825\n1 strzykawka AST 10 ml (5 ml + 5 ml)\n05909990959358 ¦ Lz ¦ Skasowane ¦ 74851\n1 system dwustrzykawkowy 2 ml (1 ml + 1 ml)\n05909990959365 ¦ Lz ¦ Skasowane ¦ 74853\n1 system dwustrzykawkowy 4 ml (2 ml + 2 ml)\n05909990959372 ¦ Lz ¦ Skasowane ¦ 74858\n1 system dwustrzykawkowy 10 ml (5 ml + 5 ml)\n05909991315870 ¦ Lz ¦ 120465\n1 strzykawka PRIMA 2 ml (1 ml + 1 ml)\n05909991315887 ¦ Lz ¦ 120466\n1 strzykawka PRIMA 4 ml (2 ml + 2 ml)\n05909991315894 ¦ Lz ¦ 120467\n1 strzykawka PRIMA 10 ml (5 ml + 5 ml)",
"substance": "Trombina 4 500 j.m. (składni 2) + Aprotininum 3000 KIU (składnik 1) + Fibrinolysinum (humanum) 91 mg (składnik 1) + Calcii chloridum dihydricum 40 mcmol (składnik 2)",
"common_name": "Preparat złożony",
"pl_product_id": "100219853",
"pozwolenie_nr": "16255",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about preparat złożony.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.